Heart Failure-USB: Prediction and Progression
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Basel, Switzerland
About this trial
This retrospective cohort study is to identify triggers of heart failure (HF) development and drivers of HF progression as well as the underlying cardiac disease (phenotype) to identify patients at risk and predict the clinical course of the disease. Data of patients who were hospitalized during the years 2010-2023 with acute coronary syndrome (ACS) and/ or with acute heart failure (AHF) will be collected and analyzed. In a subgroup cohort efficacy and safety of digoxin in patients with acute heart failure triggered by tachyarrhythmia will be evaluated.
Eligibility criteria
Qualifiers
Patients hospitalized with a primary diagnosis of ACS
Patients hospitalized with a primary or secondary diagnosis of AHF
Disqualifiers
Existence of a documented statement of the patient against the scientific use of clinical data
Trial design
Treatments tested in this trial
- medical chart review
- data generated by direct IT export
Treatment groups
6,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov